Brief: Addex Therapeutics Files For Resale Of Up To 2.45 Mln American Depositary Shares By The Selling Shareholder
07/01/2022 21:17
Jan 7 (Reuters) - Addex Therapeutics Ltd ADXN.S :
* ADDEX THERAPEUTICS LTD FILES FOR RESALE OF UP TO 2.45
MILLION
AMERICAN DEPOSITARY SHARES BY THE SELLING SHAREHOLDER - SEC
FILING
Source: (https://bit.ly/3f3NvAC)
Further company coverage: ADXN.S
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Addex Therapeutics
See all newsBrief: Addex Spin-Out Neurosterix Completes Phase 1 Clinical Studies Of NTX-253 For Schizophrenia
NASDAQ RESUMED AT 11:29 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:24 AM
Switzerland's Addex Therapeutics Q2 net loss narrows on decline in R&D expenses
Brief: Addex Therapeutics Q2 Operating Income CHF -645 Thousand